Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.25 trillion and total revenue of $117.14 billion.
Market Cap
1.25T
Revenue
117.14B
Profits
-35.29B
PE Ratio
n/a
Profit Margin
-30.12%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 131.16B | -1.23% | 1,189,036 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.65B | 0.33% | 423,959 | 15.53B |
| 3 | MRNA | Moderna, Inc. | 79.39B | -0.62% | 17,108,669 | 2.23B |
| 4 | ARGX | argenx SE | 54.57B | -0.50% | 269,569 | 5.92B |
| 5 | ONC | BeOne Medicines AG | 42.17B | -1.79% | 354,606 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 39.42B | -1.65% | 1,660,256 | - |
| 7 | RPRX | Royalty Pharma plc | 37.24B | 1.41% | 4,108,090 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.46B | 1.62% | 1,436,999 | 4.80B |
| 9 | GMAB | Genmab A/S | 26.50B | 2.04% | 7,473,718 | 4.13B |
| 10 | ROIV | Roivant Sciences Ltd. | 26.04B | -1.21% | 9,868,965 | 7.53M |
| 11 | INCY | Incyte Corporation | 22.97B | -2.07% | 2,264,061 | 5.82B |
| 12 | BNTX | BioNTech SE | 21.82B | -1.43% | 1,406,945 | 3.03B |
| 13 | INSM | Insmed Incorporated | 20.38B | -0.06% | 3,379,925 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 16.13B | 0.90% | 1,674,632 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 16.10B | 0.73% | 545,416 | 1.20B |
| 16 | HALO | Halozyme Therapeutics, Inc. | 14.53B | 1.89% | 1,237,637 | 1.66B |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 13.35B | -3.88% | 970,044 | 4.60B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.32B | -0.60% | 2,059,136 | 713.07M |
| 19 | SMMT | Summit Therapeutics Inc. | 11.60B | -6.27% | 4,782,986 | - |
| 20 | TECH | Bio-Techne Corporation | 11.40B | 0.19% | 2,798,432 | 1.22B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.79B | -0.36% | 2,360,995 | 3.41B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.11B | 0.81% | 275,872 | 1.28B |
| 23 | KYMR | Kymera Therapeutics, Inc. | 9.55B | 3.68% | 438,576 | 105.00M |
| 24 | PCVX | Vaxcyte, Inc. | 9.44B | -0.76% | 1,469,429 | - |
| 25 | CORT | Corcept Therapeutics Incorporated | 9.42B | 1.47% | 1,872,205 | 830.81M |
| 26 | KRYS | Krystal Biotech, Inc. | 9.28B | 0.69% | 223,645 | 440.48M |
| 27 | CAI | Caris Life Sciences, Inc. | 9.17B | 1.42% | 1,999,106 | 989.61M |
| 28 | TWST | Twist Bioscience Corporation | 9.11B | 3.81% | 1,379,528 | 431.80M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 9.08B | 1.37% | 823,278 | 281.99M |
| 30 | SYRE | Spyre Therapeutics, Inc. | 8.68B | 2.86% | 637,181 | - |
| 31 | CYTK | Cytokinetics, Incorporated | 8.44B | -0.82% | 783,239 | 67.67M |
| 32 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.33B | 1.65% | 979,892 | 669.50M |
| 33 | IBRX | ImmunityBio, Inc. | 8.28B | -4.99% | 11,049,308 | 165.79M |
| 34 | TGTX | TG Therapeutics, Inc. | 7.77B | 1.14% | 1,187,449 | 799.54M |
| 35 | ABVX | ABIVAX Société Anonyme | 7.60B | -1.72% | 423,694 | 5.33M |
| 36 | AXSM | Axsome Therapeutics, Inc. | 7.55B | -0.68% | 886,185 | 776.57M |
| 37 | PRAX | Praxis Precision Medicines, Inc. | 7.47B | 5.70% | 389,761 | 7.46M |
| 38 | IONS | Ionis Pharmaceuticals, Inc. | 7.22B | 1.14% | 3,197,537 | 874.09M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.24B | -2.20% | 7,442,623 | 324.97M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.16B | 0.22% | 289,450 | 239.92M |
| 41 | LGND | Ligand Pharmaceuticals Incorporated | 6.15B | 1.57% | 194,782 | 290.54M |
| 42 | ORKA | Oruka Therapeutics, Inc. | 5.98B | 12.70% | 1,942,847 | - |
| 43 | IMVT | Immunovant, Inc. | 5.82B | -0.84% | 1,195,303 | - |
| 44 | BLTE | Belite Bio, Inc | 5.77B | -2.70% | 137,152 | - |
| 45 | MANE | Veradermics, Incorporated | 5.74B | -1.00% | 392,750 | - |
| 46 | KOD | Kodiak Sciences Inc. | 5.62B | 2.25% | 927,029 | - |
| 47 | CGON | CG Oncology, Inc. | 5.46B | -0.24% | 880,160 | 6.23M |
| 48 | MIRM | Mirum Pharmaceuticals, Inc. | 5.41B | 3.58% | 429,984 | 618.07M |
| 49 | COGT | Cogent Biosciences, Inc. | 5.37B | -0.96% | 2,205,992 | - |
| 50 | ERAS | Erasca, Inc. | 5.24B | 4.17% | 6,466,123 | - |
| 51 | PTCT | PTC Therapeutics, Inc. | 5.10B | 0.79% | 708,776 | 1.01B |
| 52 | SRRK | Scholar Rock Holding Corporation | 5.08B | 0.53% | 1,678,241 | - |
| 53 | DFTX | Definium Therapeutics, Inc. | 4.79B | 0.03% | 1,054,043 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 4.74B | -0.77% | 1,066,928 | 13.39M |
| 55 | TVTX | Travere Therapeutics, Inc. | 4.71B | -0.22% | 3,341,603 | 591.33M |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.44B | 3.32% | 501,183 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.25B | -0.36% | 1,018,069 | - |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 4.00B | 1.96% | 1,547,906 | 463.98M |
| 59 | RLAY | Relay Therapeutics, Inc. | 3.97B | -0.33% | 1,585,748 | 10.35M |
| 60 | LEGN | Legend Biotech Corporation | 3.95B | 5.81% | 2,369,678 | 1.27B |
| 61 | ABCL | AbCellera Biologics Inc. | 3.91B | 2.20% | 3,038,418 | 66.17M |
| 62 | TNGX | Tango Therapeutics, Inc. | 3.74B | -4.91% | 5,370,564 | 53.81M |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.46B | 1.22% | 726,714 | 7.50M |
| 64 | IRON | Disc Medicine, Inc. | 3.45B | 4.23% | 1,222,038 | - |
| 65 | ACAD | Acadia Pharmaceuticals Inc. | 3.40B | 0.05% | 1,229,734 | 1.14B |
| 66 | CELC | Celcuity Inc. | 3.22B | 0.84% | 1,866,289 | - |
| 67 | IDYA | IDEAYA Biosciences, Inc. | 3.17B | -5.27% | 1,188,206 | 234.13M |
| 68 | PBLS | Parabilis Medicines, Inc. | 3.09B | 2.41% | 1,427,695 | 148.00K |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 3.07B | 2.68% | 877,126 | 606.33M |
| 70 | TLX | Telix Pharmaceuticals Limited | 3.05B | -1.75% | 323,417 | 890.79M |
| 71 | ELVN | Enliven Therapeutics, Inc. | 3.04B | -0.07% | 2,323,118 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 2.98B | 1.36% | 726,046 | 3.60M |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.94B | 0.64% | 1,741,944 | - |
| 74 | VKTX | Viking Therapeutics, Inc. | 2.82B | -0.78% | 3,564,093 | - |
| 75 | NRIX | Nurix Therapeutics, Inc. | 2.79B | 0.83% | 2,336,966 | 701.94M |
| 76 | ZLAB | Zai Lab Limited | 2.73B | 1.29% | 1,739,128 | 449.61M |
| 77 | VRDN | Viridian Therapeutics, Inc. | 2.64B | 4.34% | 1,515,418 | 71.13M |
| 78 | RCUS | Arcus Biosciences, Inc. | 2.52B | -4.21% | 2,699,612 | 117.00M |
| 79 | ADMA | ADMA Biologics, Inc. | 2.48B | 3.60% | 2,027,274 | 512.28M |
| 80 | MBX | MBX Biosciences, Inc. | 2.42B | 3.69% | 653,050 | - |
| 81 | BEAM | Beam Therapeutics Inc. | 2.38B | -1.08% | 1,401,452 | 156.04M |
| 82 | NAMS | NewAmsterdam Pharma Company N.V. | 2.33B | -0.91% | 1,564,211 | 7.12M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.32B | 0.85% | 593,368 | 158.00K |
| 84 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -1.73% | 3,214,377 | - |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.27B | 2.70% | 16,104,057 | 54.86M |
| 86 | AUPH | Aurinia Pharmaceuticals Inc. | 2.27B | 1.07% | 794,704 | 311.51M |
| 87 | FTRE | Fortrea Holdings Inc. | 2.27B | 0.85% | 1,040,110 | 2.68B |
| 88 | PHVS | Pharvaris N.V. | 2.21B | 0.41% | 347,676 | - |
| 89 | VCEL | Vericel Corporation | 2.20B | 1.20% | 634,753 | 306.30M |
| 90 | AGIO | Agios Pharmaceuticals, Inc. | 2.20B | -0.41% | 838,544 | 98.34M |
| 91 | BHVN | Biohaven Ltd. | 2.18B | 4.11% | 2,677,188 | - |
| 92 | XNCR | Xencor, Inc. | 2.17B | 15.89% | 8,902,707 | 104.97M |
| 93 | PGEN | Precigen, Inc. | 2.16B | -2.42% | 2,547,297 | 85.72M |
| 94 | HRMY | Harmony Biosciences Holdings, Inc. | 2.14B | 1.94% | 852,697 | 959.90M |
| 95 | VERA | Vera Therapeutics, Inc. | 2.04B | 1.11% | 1,170,807 | - |
| 96 | IMNM | Immunome, Inc. | 2.03B | -0.56% | 910,529 | 4.02M |
| 97 | LKFT | Lakefront Biotherapeutics NV | 2.02B | 0.11% | 191,351 | 1.13B |
| 98 | ZYME | Zymeworks Inc. | 2.01B | 0.53% | 833,942 | 37.13M |
| 99 | ADRX | ADARx Pharmaceuticals, Inc. | 2.00B | 1.02% | 99,579 | 6.13M |
| 100 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.97B | 3.55% | 1,285,235 | 208.78M |
| 101 | SEPN | Septerna, Inc. | 1.93B | 2.40% | 279,435 | 98.88M |
| 102 | SRPT | Sarepta Therapeutics, Inc. | 1.90B | 1.41% | 1,361,777 | 1.97B |
| 103 | VIR | Vir Biotechnology, Inc. | 1.87B | 4.45% | 1,587,362 | 303.23M |
| 104 | PVLA | Palvella Therapeutics, Inc. | 1.82B | 0.90% | 110,516 | - |
| 105 | MLYS | Mineralys Therapeutics, Inc. | 1.82B | 0.05% | 795,986 | - |
| 106 | BRVE | Braveheart Bio, Inc. | 1.79B | 2.01% | 101,221 | - |
| 107 | TRVI | Trevi Therapeutics, Inc. | 1.78B | -0.79% | 979,098 | - |
| 108 | ZBIO | Zenas BioPharma, Inc. | 1.78B | 1.38% | 371,648 | 1.00M |
| 109 | MAZE | Maze Therapeutics, Inc. | 1.73B | 0.19% | 429,417 | 20.00M |
| 110 | MESO | Mesoblast Limited | 1.69B | 0.90% | 107,349 | 120.25M |
| 111 | COAG | Hemab Therapeutics Holdings, Inc. | 1.68B | 4.71% | 269,193 | - |
| 112 | URGN | UroGen Pharma Ltd. | 1.66B | -1.30% | 670,047 | 188.73M |
| 113 | KLRA | Kailera Therapeutics, Inc. | 1.66B | -0.62% | 589,399 | - |
| 114 | STOK | Stoke Therapeutics, Inc. | 1.64B | 1.68% | 2,083,447 | 27.59M |
| 115 | ABSI | Absci Corporation | 1.62B | 2.94% | 3,374,102 | 1.56M |
| 116 | IMCR | Immunocore Holdings plc | 1.61B | 0.97% | 197,930 | 430.78M |
| 117 | NBTX | Nanobiotix S.A. | 1.60B | 7.39% | 129,727 | 13.15M |
| 118 | LYCA | Lycia Therapeutics, Inc. | 1.59B | -3.83% | 965,723 | 4.44M |
| 119 | GENB | Generate Biomedicines, Inc. | 1.59B | -0.48% | 340,898 | 26.48M |
| 120 | NUVB | Nuvation Bio Inc. | 1.58B | -1.31% | 3,663,247 | 169.90M |
| 121 | RARE | Ultragenyx Pharmaceutical Inc. | 1.58B | 2.75% | 3,023,155 | 717.00M |
| 122 | NTLA | Intellia Therapeutics, Inc. | 1.58B | 0.45% | 2,064,597 | 59.51M |
| 123 | TRAX | First Tracks Biotherapeutics, Inc. | 1.55B | -1.29% | 592,297 | - |
| 124 | NVAX | Novavax, Inc. | 1.55B | -3.09% | 4,941,085 | 413.80M |
| 125 | INVA | Innoviva, Inc. | 1.52B | 1.89% | 569,096 | 440.00M |
| 126 | GPCR | Structure Therapeutics Inc. | 1.50B | -0.42% | 688,970 | - |
| 127 | QURE | uniQure N.V. | 1.50B | -3.48% | 988,701 | 18.67M |
| 128 | KRSA | Korsana Biosciences, Inc. | 1.46B | 2.49% | 230,503 | - |
| 129 | ANAB | AnaptysBio, Inc. | 1.46B | 0.08% | 417,197 | 106.09M |
| 130 | OCUL | Ocular Therapeutix, Inc. | 1.42B | -0.46% | 1,690,501 | 52.06M |
| 131 | AAPG | Ascentage Pharma Group International | 1.41B | 0.06% | 3,075 | 94.61M |
| 132 | TYRA | Tyra Biosciences, Inc. | 1.40B | -0.15% | 790,340 | - |
| 133 | GHRS | GH Research PLC | 1.32B | 6.14% | 306,079 | - |
| 134 | DMRA | Damora Therapeutics, Inc. | 1.31B | 0.81% | 641,720 | - |
| 135 | TSHA | Taysha Gene Therapies, Inc. | 1.31B | 1.26% | 1,819,776 | 5.49M |
| 136 | INBX | Inhibrx Biosciences, Inc. | 1.30B | -5.11% | 251,184 | 1.30M |
| 137 | NKTR | Nektar Therapeutics | 1.28B | 0.62% | 532,603 | 54.59M |
| 138 | LBRX | LB Pharmaceuticals Inc | 1.27B | 1.58% | 275,975 | - |
| 139 | RAPP | Rapport Therapeutics, Inc. | 1.22B | -2.31% | 1,041,211 | 20.00M |
| 140 | VSTM | Verastem, Inc. | 1.22B | -0.40% | 4,289,252 | 87.53M |
| 141 | AVLN | Avalyn Pharma Inc. | 1.20B | 4.22% | 411,771 | - |
| 142 | SLN | Silence Therapeutics plc | 1.19B | 0.56% | 4,654,225 | 615.00K |
| 143 | DRTS | Alpha Tau Medical Ltd. | 1.19B | -2.05% | 379,083 | - |
| 144 | KARD | Kardigan, Inc. | 1.18B | -1.33% | 216,098 | - |
| 145 | SNDX | Syndax Pharmaceuticals, Inc. | 1.18B | -1.34% | 1,991,189 | 252.25M |
| 146 | OMER | Omeros Corporation | 1.18B | -1.69% | 741,394 | 38.42M |
| 147 | REPL | Replimune Group, Inc. | 1.17B | 8.81% | 2,045,760 | - |
| 148 | SVRA | Savara Inc. | 1.15B | 7.11% | 3,449,003 | - |
| 149 | BCAX | Bicara Therapeutics Inc. | 1.12B | -1.05% | 1,051,906 | - |
| 150 | SPTX | Seaport Therapeutics, Inc. | 1.12B | 1.07% | 124,687 | - |
| 151 | VOR | Vor Biopharma Inc. | 1.08B | 0.38% | 470,344 | - |
| 152 | MNKD | MannKind Corporation | 1.04B | 1.25% | 1,976,552 | 393.63M |
| 153 | CTY | City Therapeutics, Inc. | 1.03B | 0.10% | 136,061 | 14.34M |
| 154 | JANX | Janux Therapeutics, Inc. | 1.02B | 0.18% | 379,225 | 24.00M |
| 155 | LTGO | Latigo Biotherapeutics, Inc. | 1.01B | 1.60% | 165,324 | - |
| 156 | MLTX | MoonLake Immunotherapeutics | 1.01B | -0.34% | 1,514,732 | - |
| 157 | SGP | SpyGlass Pharma, Inc. | 1.00B | 5.02% | 89,404 | - |
| 158 | IMTX | Immatics N.V. | 977.33M | -2.19% | 756,093 | 47.65M |
| 159 | CGEM | Cullinan Therapeutics, Inc. | 935.72M | 1.18% | 438,575 | - |
| 160 | RIGL | Rigel Pharmaceuticals, Inc. | 932.31M | 3.70% | 196,564 | 276.79M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 928.21M | -32.00% | 6,952,474 | - |
| 162 | ODTX | Odyssey Therapeutics, Inc. | 924.83M | -1.53% | 139,919 | 99.00K |
| 163 | JBIO | Jade Biosciences, Inc. | 922.16M | -0.62% | 477,456 | - |
| 164 | GLUE | Monte Rosa Therapeutics, Inc. | 894.08M | -3.32% | 1,227,112 | 28.73M |
| 165 | IVA | Inventiva S.A. | 891.80M | -1.35% | 3,332,166 | 2.81M |
| 166 | MGTX | MeiraGTx Holdings plc | 881.67M | -0.33% | 649,158 | 397.50M |
| 167 | CRVS | Corvus Pharmaceuticals, Inc. | 879.06M | -0.76% | 981,131 | - |
| 168 | AKTS | Aktis Oncology, Inc. | 874.89M | - | 149,999 | 10.06M |
| 169 | ANRO | Alto Neuroscience, Inc. | 867.64M | 0.64% | 550,065 | - |
| 170 | OBX | Obsidian Therapeutics, Inc. | 856.17M | -0.86% | 204,801 | - |
| 171 | KURA | Kura Oncology, Inc. | 855.80M | 0.10% | 865,013 | 77.23M |
| 172 | ALMS | Alumis Inc. | 842.62M | -3.98% | 1,119,974 | 7.40M |
| 173 | PHAR | Pharming Group N.V. | 834.27M | 6.25% | 43,472 | 386.75M |
| 174 | ABUS | Arbutus Biopharma Corporation | 830.96M | - | 1,405,376 | 181.72M |
| 175 | APMD | Apnimed, Inc. | 788.90M | -0.21% | 178,554 | 115.12M |
| 176 | AVBP | ArriVent BioPharma, Inc. | 757.37M | -26.86% | 5,947,635 | - |
| 177 | HELP | Helus Pharma Inc. | 756.90M | 1.67% | 1,033,739 | - |
| 178 | ARDX | Ardelyx, Inc. | 747.56M | -2.60% | 5,000,625 | 450.89M |
| 179 | GERN | Geron Corporation | 738.84M | 2.68% | 11,089,634 | 204.56M |
| 180 | SANA | Sana Biotechnology, Inc. | 706.49M | 1.29% | 1,509,345 | - |
| 181 | ANNX | Annexon, Inc. | 701.44M | -1.33% | 2,648,827 | - |
| 182 | SLBT | SL Science Holding Limited | 701.43M | 6.96% | 52,457 | 3.27M |
| 183 | IAM | Iambic Therapeutics, Inc. | 683.05M | 1.05% | 149,160 | 18.25M |
| 184 | ANL | Adlai Nortye Group Ltd. | 681.33M | - | 132,936 | 18.06M |
| 185 | SGMT | Sagimet Biosciences Inc. | 677.89M | -0.21% | 767,188 | - |
| 186 | DNA | Ginkgo Bioworks Holdings, Inc. | 674.75M | 0.30% | 1,270,147 | 132.42M |
| 187 | ACHV | Achieve Life Sciences, Inc. | 672.98M | 0.77% | 701,512 | - |
| 188 | OABI | OmniAb, Inc. | 670.25M | -1.07% | 971,630 | 38.46M |
| 189 | IMMX | Immix Biopharma, Inc. | 668.20M | -1.10% | 1,116,379 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 647.09M | 0.98% | 316,692 | - |
| 191 | LXRX | Lexicon Pharmaceuticals, Inc. | 645.19M | 2.11% | 2,205,901 | 41.47M |
| 192 | GYRE | Gyre Therapeutics, Inc. | 643.62M | 3.76% | 93,375 | 109.82M |
| 193 | PRME | Prime Medicine, Inc. | 642.23M | -1.63% | 2,511,564 | 4.07M |
| 194 | AURA | Aura Biosciences, Inc. | 640.90M | -1.90% | 907,586 | - |
| 195 | ATTO | Attovia Therapeutics, Inc. | 633.64M | 0.36% | 224,637 | 1.80M |
| 196 | WVE | Wave Life Sciences, Inc. | 632.52M | 0.94% | 3,224,224 | 65.37M |
| 197 | SLDB | Solid Biosciences Inc. | 622.98M | -1.86% | 1,070,935 | - |
| 198 | CRMD | CorMedix Inc. | 618.88M | 1.15% | 1,130,294 | 462.25M |
| 199 | FDMT | 4D Molecular Therapeutics, Inc. | 609.34M | 2.13% | 1,084,579 | 92.01M |
| 200 | NVCT | Nuvectis Pharma, Inc. | 602.43M | -7.78% | 318,836 | - |
| 201 | CADL | Candel Therapeutics, Inc. | 596.08M | -2.99% | 849,302 | - |
| 202 | DBVT | DBV Technologies S.A. | 593.02M | 2.36% | 214,829 | 5.04M |
| 203 | OLMA | Olema Pharmaceuticals, Inc. | 579.23M | 3.28% | 1,987,373 | - |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 565.93M | -2.85% | 722,197 | 136.07M |
| 205 | MDXG | MiMedx Group, Inc. | 561.18M | -1.53% | 1,109,256 | 355.17M |
| 206 | PBYI | Puma Biotechnology, Inc. | 560.08M | -1.54% | 355,705 | 231.24M |
| 207 | ACRS | Aclaris Therapeutics, Inc. | 557.88M | 1.07% | 1,572,733 | 8.22M |
| 208 | STTK | Shattuck Labs, Inc. | 556.01M | 0.91% | 706,098 | 1.00M |
| 209 | CBIO | Crescent Biopharma, Inc. | 546.14M | -0.47% | 210,637 | 11.88M |
| 210 | ETRA | Electra Therapeutics, Inc. | 525.36M | -3.90% | 159,130 | - |
| 211 | BLSM | BlossomHill Therapeutics, Inc. | 520.95M | 12.03% | 204,368 | - |
| 212 | VALN | Valneva SE | 513.03M | 2.85% | 21,301 | 163.30M |
| 213 | DRUG | Bright Minds Biosciences Inc. | 513.00M | -2.65% | 89,060 | - |
| 214 | INDP | Indaptus Therapeutics, Inc. | 512.96M | 5.70% | 352,844 | - |
| 215 | CLYM | Climb Bio, Inc. | 506.01M | -13.54% | 3,381,239 | - |
| 216 | ENTX | Entera Bio Ltd. | 497.42M | -2.05% | 232,467 | 42.00K |
| 217 | OCS | Oculis Holding AG | 491.39M | 0.76% | 206,966 | 1.45M |
| 218 | CTMX | CytomX Therapeutics, Inc. | 484.83M | -4.09% | 5,224,019 | 18.30M |
| 219 | ARVN | Arvinas, Inc. | 477.97M | 0.14% | 724,862 | 316.70M |
| 220 | SRZN | Surrozen, Inc. | 477.27M | 7.06% | 511,217 | 11.51M |
| 221 | MNPR | Monopar Therapeutics Inc. | 473.48M | -0.16% | 84,703 | - |
| 222 | PHAT | Phathom Pharmaceuticals, Inc. | 471.81M | 3.48% | 2,113,849 | 239.66M |
| 223 | DMAC | DiaMedica Therapeutics Inc. | 471.31M | 0.23% | 129,605 | - |
| 224 | NGNE | Neurogene Inc. | 471.07M | -0.04% | 123,203 | 925.00K |
| 225 | EPRX | Eupraxia Pharmaceuticals Inc. | 448.96M | -0.29% | 540,288 | - |
| 226 | FTH | Faeth Therapeutics, Inc. | 434.89M | -1.46% | 424,470 | - |
| 227 | RGNX | REGENXBIO Inc. | 434.37M | -1.50% | 1,138,425 | 174.48M |
| 228 | PRTA | Prothena Corporation plc | 431.23M | 2.44% | 594,545 | 54.53M |
| 229 | MPLT | MapLight Therapeutics, Inc. | 425.71M | -3.89% | 252,612 | - |
| 230 | AGMB | AgomAb Therapeutics NV | 422.06M | -5.30% | 73,851 | - |
| 231 | OVID | Ovid Therapeutics Inc. | 420.87M | -0.23% | 844,073 | 1.58M |
| 232 | ALLO | Allogene Therapeutics, Inc. | 418.04M | -3.20% | 10,576,386 | 4.64M |
| 233 | PROK | ProKidney Corp. | 411.16M | -3.55% | 761,676 | 818.00K |
| 234 | AUTL | Autolus Therapeutics plc | 407.23M | -0.65% | 1,237,587 | 117.39M |
| 235 | RZLT | Rezolute, Inc. | 400.71M | -0.91% | 1,543,501 | - |
| 236 | ASMB | Assembly Biosciences, Inc. | 400.49M | -0.86% | 152,227 | 74.85M |
| 237 | ALT | Altimmune, Inc. | 398.76M | -3.30% | 3,498,573 | 31.00K |
| 238 | TECX | Tectonic Therapeutic, Inc. | 390.01M | -0.60% | 151,223 | - |
| 239 | SPRY | ARS Pharmaceuticals, Inc. | 389.83M | -2.73% | 1,433,831 | 116.93M |
| 240 | PRLD | Prelude Therapeutics Incorporated | 381.08M | 1.93% | 236,859 | 22.42M |
| 241 | YDES | YD Bio Limited | 374.70M | 6.87% | 59,784 | 1.24M |
| 242 | TRXB | TRex Bio, Inc. | 373.41M | 0.43% | 54,977 | - |
| 243 | EDIT | Editas Medicine, Inc. | 368.59M | - | 1,350,905 | 47.01M |
| 244 | CCCC | C4 Therapeutics, Inc. | 366.61M | -2.61% | 3,179,138 | 35.04M |
| 245 | AVTX | Avalo Therapeutics, Inc. | 363.08M | -2.31% | 2,370,682 | 59.00K |
| 246 | FENC | Fennec Pharmaceuticals Inc. | 355.93M | 0.69% | 115,943 | 59.22M |
| 247 | ENTA | Enanta Pharmaceuticals, Inc. | 349.50M | 3.09% | 440,616 | 65.26M |
| 248 | RLMD | Relmada Therapeutics, Inc. | 344.54M | -1.22% | 775,832 | - |
| 249 | ZURA | Zura Bio Limited | 341.15M | 5.95% | 4,294,908 | - |
| 250 | CAPR | Capricor Therapeutics, Inc. | 333.72M | -3.20% | 1,552,916 | 11.13M |
| 251 | AVIR | Atea Pharmaceuticals, Inc. | 333.65M | 2.97% | 251,086 | - |
| 252 | OBIO | Orchestra BioMed Holdings, Inc. | 333.58M | -0.72% | 242,657 | 31.98M |
| 253 | KYTX | Kyverna Therapeutics, Inc. | 325.91M | -2.23% | 810,112 | - |
| 254 | XFOR | X4 Pharmaceuticals, Inc. | 322.23M | 0.31% | 701,647 | 15.85M |
| 255 | GALT | Galectin Therapeutics Inc. | 321.71M | - | 164,393 | - |
| 256 | VTVT | vTv Therapeutics Inc. | 320.68M | 1.02% | 15,118 | 36.84M |
| 257 | TTRX | Turn Therapeutics Inc. | 316.05M | 3.21% | 98,177 | - |
| 258 | NAUT | Nautilus Biotechnology, Inc. | 310.50M | -24.69% | 16,590,370 | 190.00K |
| 259 | CTNM | Contineum Therapeutics, Inc. | 306.24M | -2.05% | 402,684 | - |
| 260 | ARTV | Artiva Biotherapeutics, Inc. | 301.16M | 0.16% | 487,078 | 251.00K |
| 261 | EIKN | Eikon Therapeutics, Inc. | 300.07M | -23.69% | 965,950 | - |
| 262 | BNTC | Benitec Biopharma Inc. | 299.64M | -0.69% | 98,628 | - |
| 263 | SCTX | Scribe Therapeutics Inc. | 295.33M | 1.27% | 348,751 | 33.30M |
| 264 | ARCT | Arcturus Therapeutics Holdings Inc. | 281.67M | 0.71% | 595,709 | 29.37M |
| 265 | FULC | Fulcrum Therapeutics, Inc. | 277.72M | -1.09% | 773,327 | 80.00M |
| 266 | AGEN | Agenus Inc. | 277.33M | -2.69% | 687,894 | 132.69M |
| 267 | IKT | Inhibikase Therapeutics, Inc. | 276.75M | -4.40% | 860,474 | 1.00 |
| 268 | IRD | Opus Genetics, Inc. | 276.21M | -4.32% | 1,520,405 | 9.86M |
| 269 | ALEC | Alector, Inc. | 271.31M | - | 2,659,496 | 13.86M |
| 270 | VCRE | Vicore Pharma Holding AB (publ) | 263.56M | 0.21% | 3,981 | 412.09K |
| 271 | VOGX | Vogenx, Inc. | 257.59M | -0.63% | 105,989 | - |
| 272 | IPSC | Century Therapeutics, Inc. | 257.13M | -2.74% | 493,661 | 109.16M |
| 273 | BCYC | Bicycle Therapeutics plc | 255.47M | 2.82% | 525,955 | 61.21M |
| 274 | CUVL | Clinuvel Pharmaceuticals Limited | 254.81M | 0.40% | 5,321 | 65.05M |
| 275 | SABS | SAB Biotherapeutics, Inc. | 253.85M | -1.76% | 324,518 | 114.70K |
| 276 | LCTX | Lineage Cell Therapeutics, Inc. | 252.12M | -0.31% | 1,908,143 | 13.08M |
| 277 | QTTB | Q32 Bio Inc. | 251.55M | -2.31% | 563,885 | 53.74M |
| 278 | GLSI | Greenwich LifeSciences, Inc. | 251.36M | 6.83% | 118,890 | - |
| 279 | RCKT | Rocket Pharmaceuticals, Inc. | 250.29M | -0.44% | 1,514,758 | - |
| 280 | ABEO | Abeona Therapeutics Inc. | 246.46M | -2.05% | 426,579 | 25.52M |
| 281 | FATE | Fate Therapeutics, Inc. | 246.23M | -2.61% | 1,460,286 | 6.49M |
| 282 | OCGN | Ocugen, Inc. | 240.23M | -4.23% | 8,310,361 | 4.58M |
| 283 | IMRX | Immuneering Corporation | 240.03M | -0.54% | 579,803 | - |
| 284 | VNDA | Vanda Pharmaceuticals Inc. | 238.22M | -1.75% | 810,903 | 215.72M |
| 285 | LRMR | Larimar Therapeutics, Inc. | 233.82M | -4.68% | 1,310,125 | - |
| 286 | IFRX | InflaRx N.V. | 232.10M | 0.96% | 397,590 | -11.54K |
| 287 | ACIU | AC Immune SA | 229.68M | -4.55% | 397,920 | 21.67M |
| 288 | CABA | Cabaletta Bio, Inc. | 228.89M | -8.16% | 6,237,003 | - |
| 289 | LYEL | Lyell Immunopharma, Inc. | 228.14M | -0.85% | 85,217 | 27.00K |
| 290 | SLGL | Sol-Gel Technologies Ltd. | 227.97M | 0.26% | 47,644 | 1.80M |
| 291 | KROS | Keros Therapeutics, Inc. | 224.64M | 0.44% | 112,410 | 15.01M |
| 292 | LXEO | Lexeo Therapeutics, Inc. | 221.51M | -3.57% | 1,162,582 | - |
| 293 | PALI | Palisade Bio, Inc. | 214.35M | -7.52% | 1,704,298 | 500.00K |
| 294 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 211.66M | -0.75% | 483,081 | - |
| 295 | PYXS | Pyxis Oncology, Inc. | 201.88M | 0.60% | 645,784 | 11.04M |
| 296 | CAMP | Camp4 Therapeutics Corporation | 201.44M | -2.73% | 60,108 | 4.22M |
| 297 | PLX | Protalix BioTherapeutics, Inc. | 199.82M | -2.75% | 416,271 | 80.62M |
| 298 | ZNTL | Zentalis Pharmaceuticals, Inc. | 195.97M | -6.33% | 1,057,358 | 26.87M |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 190.00M | 1.62% | 105,633 | 1.48M |
| 300 | EVMN | Evommune, Inc. | 186.18M | 0.59% | 322,218 | 10.00M |
| 301 | YARW | Yarrow Bioscience, Inc. | 186.09M | 3.79% | 162,233 | - |
| 302 | ACOG | Alpha Cognition Inc. | 180.76M | -0.48% | 89,824 | 15.26M |
| 303 | ELDN | Eledon Pharmaceuticals, Inc. | 179.76M | -3.91% | 654,703 | - |
| 304 | WHWK | Whitehawk Therapeutics, Inc. | 179.01M | -2.18% | 235,791 | 7.15M |
| 305 | CGEN | Compugen Ltd. | 177.61M | -3.35% | 334,470 | 74.00M |
| 306 | KRRO | Korro Bio, Inc. | 177.00M | 0.33% | 183,160 | 2.38M |
| 307 | DTIL | Precision BioSciences, Inc. | 176.93M | -3.46% | 266,678 | 45.06M |
| 308 | PRQR | ProQR Therapeutics N.V. | 174.99M | -3.88% | 939,064 | 21.05M |
| 309 | IVVD | Invivyd, Inc. | 173.67M | -3.95% | 2,830,329 | 58.37M |
| 310 | PEPG | PepGen Inc. | 172.46M | -1.19% | 906,889 | - |
| 311 | TRDA | Entrada Therapeutics, Inc. | 171.27M | 7.71% | 617,087 | 4.69M |
| 312 | ORMP | Oramed Pharmaceuticals Inc. | 169.72M | -1.21% | 109,119 | 2.00M |
| 313 | ADAG | Adagene Inc. | 167.19M | 3.32% | 91,198 | 9.29M |
| 314 | SION | Sionna Therapeutics, Inc. | 166.83M | 2.50% | 614,224 | - |
| 315 | ABOS | Acumen Pharmaceuticals, Inc. | 164.18M | 14.65% | 1,649,956 | - |
| 316 | ALXO | ALX Oncology Holdings Inc. | 156.25M | -3.42% | 1,037,530 | - |
| 317 | CHRS | Coherus Oncology, Inc. | 156.05M | - | 686,793 | 50.94M |
| 318 | MDWD | MediWound Ltd. | 155.76M | 0.54% | 83,893 | 11.86M |
| 319 | NGEN | NervGen Pharma Corp. | 152.68M | -0.70% | 259,169 | - |
| 320 | UPB | Upstream Bio, Inc. | 150.62M | 0.36% | 983,845 | 3.16M |
| 321 | STRO | Sutro Biopharma, Inc. | 147.32M | -4.77% | 694,467 | 45.70M |
| 322 | MOLN | Molecular Partners AG | 146.78M | -2.18% | 1,626 | 856.30K |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 145.02M | -2.15% | 514,183 | 1.50M |
| 324 | CDXS | Codexis, Inc. | 142.36M | 1.56% | 392,377 | 77.68M |
| 325 | MSLE | Satellos Bioscience Inc. | 141.20M | 1.87% | 56,717 | - |
| 326 | NBP | NovaBridge Biosciences | 140.94M | -11.31% | 828,469 | - |
| 327 | MGNX | MacroGenics, Inc. | 139.50M | -2.67% | 2,606,646 | 175.14M |
| 328 | TARA | Protara Therapeutics, Inc. | 138.87M | 0.86% | 892,649 | - |
| 329 | VRXA | Veraxa Biotech AG | 138.58M | -2.00% | 162,840 | 29.54K |
| 330 | RNA | Atrium Therapeutics, Inc. | 137.70M | -1.83% | 187,419 | 35.84M |
| 331 | ANTX | AN2 Therapeutics, Inc. | 136.98M | 2.25% | 196,184 | - |
| 332 | IPHA | Innate Pharma S.A. | 136.43M | -2.67% | 21,882 | 11.21M |
| 333 | CMPX | Compass Therapeutics, Inc. | 134.56M | -1.81% | 2,241,927 | 850.00K |
| 334 | CUE | Cue Biopharma, Inc. | 134.03M | -1.13% | 181,715 | 37.66M |
| 335 | MENS | Jyong Biotech Ltd. | 131.39M | - | 33,616 | - |
| 336 | NKTX | Nkarta, Inc. | 131.07M | 2.23% | 1,152,304 | - |
| 337 | HURA | TuHURA Biosciences, Inc. | 130.00M | -6.42% | 636,507 | - |
| 338 | ARMP | Armata Pharmaceuticals, Inc. | 128.28M | -5.22% | 63,647 | 5.54M |
| 339 | SPRB | Spruce Biosciences, Inc. | 126.43M | -2.57% | 66,483 | 697.00K |
| 340 | OTLK | Outlook Therapeutics, Inc. | 124.96M | -1.16% | 2,529,684 | -1.16M |
| 341 | FHTX | Foghorn Therapeutics Inc. | 121.74M | 2.50% | 509,746 | 36.74M |
| 342 | AVXL | Anavex Life Sciences Corp. | 118.65M | -3.76% | 912,377 | - |
| 343 | RTSN | Retension Pharmaceuticals, Inc. | 118.64M | -6.62% | 47,187 | - |
| 344 | TLSA | Tiziana Life Sciences Ltd | 112.96M | -7.14% | 377,668 | - |
| 345 | HUMA | Humacyte, Inc. | 111.29M | -7.99% | 3,975,817 | 2.12M |
| 346 | NRXP | NRx Pharmaceuticals, Inc. | 110.32M | 2.41% | 594,734 | 3.39M |
| 347 | KZIA | Kazia Therapeutics Limited | 107.85M | 0.77% | 189,221 | 1.27M |
| 348 | VYGR | Voyager Therapeutics, Inc. | 107.83M | 0.57% | 1,662,210 | 34.46M |
| 349 | PYPD | PolyPid Ltd. | 107.45M | 0.76% | 96,685 | - |
| 350 | SEER | Seer, Inc. | 106.87M | -2.03% | 59,311 | 14.22M |
| 351 | CBUS | Cibus, Inc. | 106.62M | -1.06% | 51,288 | 4.35M |
| 352 | ENGN | enGene Therapeutics Inc. | 105.89M | 1.28% | 657,823 | - |
| 353 | NERV | Minerva Neurosciences, Inc. | 105.04M | -4.35% | 173,148 | - |
| 354 | VANI | Vivani Medical, Inc. | 101.93M | 1.80% | 122,722 | - |
| 355 | ANIX | Anixa Biosciences, Inc. | 101.86M | -2.01% | 135,639 | - |
| 356 | OKUR | OnKure Therapeutics, Inc. | 100.23M | -1.79% | 258,091 | - |
| 357 | UNCY | Unicycive Therapeutics, Inc. | 99.72M | -7.97% | 1,326,845 | - |
| 358 | IMUX | Immunic, Inc. | 99.33M | -1.75% | 432,289 | - |
| 359 | LENZ | LENZ Therapeutics, Inc. | 98.82M | -0.47% | 389,145 | 21.48M |
| 360 | TVGN | Tevogen Inc. | 98.35M | -4.29% | 9,429 | - |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 97.10M | -10.11% | 862,917 | 70.00M |
| 362 | TENX | Tenax Therapeutics, Inc. | 93.94M | -4.65% | 1,264,090 | - |
| 363 | ICCC | ImmuCell Corporation | 93.00M | -0.10% | 2,557 | 30.68M |
| 364 | COYA | Coya Therapeutics, Inc. | 92.66M | 0.25% | 129,573 | 8.02M |
| 365 | TNYA | Tenaya Therapeutics, Inc. | 91.62M | 5.04% | 3,440,519 | 1.34M |
| 366 | NRXS | NeurAxis, Inc. | 91.04M | -2.03% | 84,853 | 5.32M |
| 367 | TNXP | Tonix Pharmaceuticals Holding Corp. | 90.90M | 2.51% | 667,490 | 29.10M |
| 368 | MIST | Milestone Pharmaceuticals Inc. | 90.80M | -0.59% | 802,492 | 2.34M |
| 369 | PLYX | Polaryx Therapeutics, Inc. | 90.72M | -1.62% | 27,517 | - |
| 370 | INO | Inovio Pharmaceuticals, Inc. | 89.94M | -3.04% | 2,965,854 | 65.34K |
| 371 | RLYB | Rallybio Corporation | 88.42M | 0.06% | 6,135 | 646.00K |
| 372 | RANI | Rani Therapeutics Holdings, Inc. | 86.03M | 1.86% | 303,055 | 4.88M |
| 373 | GNLX | Genelux Corporation | 85.59M | -4.50% | 494,702 | 8.00K |
| 374 | PMVP | PMV Pharmaceuticals, Inc. | 85.33M | -11.02% | 648,580 | - |
| 375 | ATRA | Atara Biotherapeutics, Inc. | 83.81M | -2.79% | 35,268 | 6.19M |
| 376 | CNXU | Conexeu Sciences Inc. | 82.93M | -5.16% | 300,049 | - |
| 377 | EQ | Equillium, Inc. | 79.26M | 1.63% | 210,787 | 4.39M |
| 378 | PDSB | PDS Biotechnology Corporation | 77.19M | -4.05% | 2,289,265 | - |
| 379 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 77.17M | -1.48% | 847,373 | - |
| 380 | CLLS | Cellectis S.A. | 76.30M | -1.38% | 45,335 | 63.82M |
| 381 | OKYO | OKYO Pharma Limited | 75.57M | 2.86% | 16,655 | - |
| 382 | CING | Cingulate Inc. | 75.33M | 4.02% | 229,893 | - |
| 383 | NMRA | Neumora Therapeutics, Inc. | 73.82M | 3.56% | 512,157 | - |
| 384 | ACRV | Acrivon Therapeutics, Inc. | 73.71M | -0.58% | 259,134 | - |
| 385 | TELO | Telomir Pharmaceuticals, Inc. | 73.51M | 2.40% | 46,828 | - |
| 386 | NTRB | Nutriband Inc. | 72.57M | 3.65% | 26,645 | 1.62M |
| 387 | PMN | ProMIS Neurosciences, Inc. | 72.28M | -3.36% | 21,999 | - |
| 388 | NTHI | NeOnc Technologies Holdings, Inc. | 70.10M | -13.76% | 235,533 | 39.99K |
| 389 | MNOV | MediciNova, Inc. | 68.91M | 0.72% | 89,907 | 920.48K |
| 390 | CSBR | Champions Oncology, Inc. | 67.64M | 2.97% | 15,126 | 60.66M |
| 391 | MAIA | MAIA Biotechnology, Inc. | 67.52M | -3.48% | 279,981 | - |
| 392 | CGTX | Cognition Therapeutics, Inc. | 66.08M | -3.32% | 296,669 | - |
| 393 | CRDF | Cardiff Oncology, Inc. | 62.57M | -11.35% | 868,019 | 508.00K |
| 394 | FBIO | Fortress Biotech, Inc. | 62.37M | -3.11% | 116,324 | 68.47M |
| 395 | SPRO | Spero Therapeutics, Inc. | 62.31M | -3.60% | 513,867 | 47.00M |
| 396 | ONCY | Oncolytics Biotech Inc. | 60.34M | -5.79% | 711,689 | - |
| 397 | RNXT | RenovoRx, Inc. | 59.12M | 1.55% | 182,306 | 1.98M |
| 398 | VRCA | Verrica Pharmaceuticals Inc. | 58.75M | -3.12% | 21,942 | 30.32M |
| 399 | PTHS | Pelthos Therapeutics Inc. | 58.19M | -10.59% | 22,810 | 43.30M |
| 400 | HRTX | Heron Therapeutics, Inc. | 57.09M | -0.69% | 1,056,082 | 151.18M |
| 401 | XBIT | XBiotech Inc. | 56.40M | -4.15% | 136,292 | - |
| 402 | GOSS | Gossamer Bio, Inc. | 55.96M | -4.79% | 250,873 | 53.29M |
| 403 | OSTX | OS Therapies Incorporated | 55.91M | -3.20% | 247,661 | - |
| 404 | BOLD | Boundless Bio, Inc. | 54.82M | 2.12% | 59,100 | - |
| 405 | CLNN | Clene Inc. | 54.58M | -1.03% | 33,861 | 197.00K |
| 406 | ALPS | Alps Group Inc | 54.51M | -0.12% | 8,974 | 3.74M |
| 407 | HYFT | MindWalk Holdings Corp. | 54.18M | -0.86% | 157,138 | 11.57M |
| 408 | CNTB | Connect Biopharma Holdings Limited | 53.46M | 10.75% | 1,747,794 | 2.95M |
| 409 | INKT | MiNK Therapeutics, Inc. | 53.22M | -2.61% | 13,320 | - |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 53.16M | 2.89% | 26,667 | - |
| 411 | CRBU | Caribou Biosciences, Inc. | 52.77M | -7.62% | 1,934,477 | 10.04M |
| 412 | PLRX | Pliant Therapeutics, Inc. | 52.62M | -1.60% | 298,916 | - |
| 413 | RNTX | Rein Therapeutics Inc. | 50.31M | 0.19% | 394,139 | - |
| 414 | GANX | Gain Therapeutics, Inc. | 50.19M | -8.73% | 811,025 | - |
| 415 | XLO | Xilio Therapeutics, Inc. | 48.10M | -3.43% | 33,453 | 64.09M |
| 416 | HOWL | Werewolf Therapeutics, Inc. | 47.66M | 0.05% | 477,481 | 21.00M |
| 417 | BMEA | Biomea Fusion, Inc. | 46.07M | 5.92% | 1,529,169 | - |
| 418 | IMA | ImageneBio, Inc. | 45.97M | -4.03% | 32,901 | 800.00K |
| 419 | IBIO | iBio, Inc. | 45.47M | -1.50% | 509,285 | 100.00K |
| 420 | LONA | LeonaBio, Inc. | 44.85M | -1.65% | 38,900 | - |
| 421 | ELTX | Elicio Therapeutics, Inc. | 44.68M | -10.53% | 423,011 | - |
| 422 | HYPD | Hyperion DeFi, Inc. | 44.29M | 1.79% | 195,773 | 1.40M |
| 423 | ATNM | Actinium Pharmaceuticals, Inc. | 44.02M | -7.89% | 205,864 | 35.09M |
| 424 | MREO | Mereo BioPharma Group plc | 43.92M | -2.38% | 313,507 | 500.00K |
| 425 | APLM | Apollomics, Inc. | 43.70M | -8.88% | 91,520 | 8.84M |
| 426 | SER | Serina Therapeutics, Inc. | 43.43M | 3.64% | 38,290 | 130.00K |
| 427 | KLRS | Kalaris Therapeutics, Inc. | 42.85M | -3.74% | 36,034 | - |
| 428 | ACET | Adicet Bio, Inc. | 42.41M | -1.25% | 162,814 | - |
| 429 | ANVS | Annovis Bio, Inc. | 40.77M | -4.23% | 593,160 | - |
| 430 | ESLA | Estrella Immunopharma, Inc. | 39.97M | -6.72% | 2,585,588 | - |
| 431 | INMB | INmune Bio Inc. | 39.69M | -2.05% | 162,787 | 50.00K |
| 432 | GRDX | GridAI Technologies Corp. | 39.30M | -1.07% | 56,060 | - |
| 433 | ALDX | Aldeyra Therapeutics, Inc. | 38.71M | -1.23% | 786,363 | - |
| 434 | ATHE | Alterity Therapeutics Limited | 38.59M | -0.48% | 7,915 | 2.50M |
| 435 | GRCE | Grace Therapeutics, Inc. | 38.08M | -6.22% | 487,802 | - |
| 436 | TIL | Instil Bio, Inc. | 37.78M | -4.62% | 36,689 | - |
| 437 | DWTX | Dogwood Therapeutics, Inc. | 37.73M | -0.89% | 39,509 | - |
| 438 | VERU | Veru Inc. | 37.68M | -1.34% | 86,579 | 16.89M |
| 439 | EDSA | Edesa Biotech, Inc. | 34.99M | -6.50% | 63,895 | - |
| 440 | EXOZ | eXoZymes, Inc. | 34.81M | -6.25% | 16,573 | -700.00 |
| 441 | NNVC | NanoViricides, Inc. | 34.71M | -2.86% | 220,950 | - |
| 442 | LITS | Lite Strategy, Inc. | 34.06M | -3.45% | 163,455 | - |
| 443 | CRVO | CervoMed Inc. | 33.87M | -3.03% | 103,966 | 331.30K |
| 444 | IRLA | IRulya Therapeutics Inc. | 31.92M | -5.14% | 53,173 | - |
| 445 | IBO | Impact BioMedical Inc. | 31.87M | 3.61% | 12,613 | 35.00K |
| 446 | EYPT | EyePoint, Inc. | 31.53M | -9.59% | 11,125,083 | 2.79M |
| 447 | BCTX | BriaCell Therapeutics Corp. | 30.22M | 1.89% | 56,569 | - |
| 448 | FLNA | Filana Therapeutics, Inc. | 29.55M | -3.73% | 297,216 | - |
| 449 | ALGS | Aligos Therapeutics, Inc. | 29.04M | -2.72% | 33,001 | 31.52M |
| 450 | MGX | Metagenomi Therapeutics, Inc. | 28.99M | -4.74% | 224,816 | 13.56M |
| 451 | RNAZ | TransCode Therapeutics, Inc. | 28.88M | -3.64% | 54,291 | - |
| 452 | BSEM | BioStem Technologies, Inc. | 28.62M | -1.91% | 169,463 | 34.59M |
| 453 | CVM | CEL-SCI Corporation | 27.97M | -3.05% | 106,855 | - |
| 454 | ABVC | ABVC BioPharma, Inc. | 27.26M | 0.96% | 36,597 | 797.92K |
| 455 | IGC | IGC Pharma, Inc. | 25.84M | 1.59% | 331,049 | 1.11M |
| 456 | EVAX | Evaxion A/S | 25.69M | -18.09% | 220,554 | 7.49M |
| 457 | ATOS | Atossa Therapeutics, Inc. | 24.45M | -5.77% | 35,078 | - |
| 458 | CELU | Celularity Inc. | 24.34M | -23.29% | 629,002 | 18.67M |
| 459 | NXTC | NextCure, Inc. | 23.92M | 4.92% | 25,400 | - |
| 460 | AARD | Aardvark Therapeutics, Inc. | 23.64M | -22.30% | 4,957,721 | - |
| 461 | IMMP | Immutep Limited | 22.75M | -3.13% | 26,999 | 13.79M |
| 462 | CNTX | Context Therapeutics Inc. | 22.04M | 0.25% | 581,085 | - |
| 463 | PLRZ | Polyrizon Ltd. | 21.75M | 2.60% | 15,889 | - |
| 464 | MCRB | Seres Therapeutics, Inc. | 19.89M | -5.26% | 53,066 | 1.88M |
| 465 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.26M | -0.25% | 14,891 | - |
| 466 | BYSI | BeyondSpring Inc. | 18.92M | 6.70% | 51,950 | 1.88M |
| 467 | COCP | Cocrystal Pharma, Inc. | 18.72M | 2.31% | 21,940 | 330.00K |
| 468 | QNTM | Quantum BioPharma Ltd. | 18.71M | -1.34% | 176,513 | - |
| 469 | NEUP | Neuphoria Therapeutics Inc. | 18.29M | -1.74% | 26,699 | 1.17M |
| 470 | KYNB | Kyntra Bio, Inc. | 18.22M | -1.75% | 30,073 | 4.62M |
| 471 | AKTX | Akari Therapeutics, Plc | 17.44M | -7.29% | 67,835 | - |
| 472 | JSPR | Jasper Therapeutics, Inc. | 16.82M | -0.90% | 396,740 | - |
| 473 | RADX | Radiopharm Theranostics Limited | 15.22M | -1.39% | 17,271 | 8.90M |
| 474 | DYAI | Dyadic International, Inc. | 15.16M | 4.26% | 87,988 | 3.80M |
| 475 | MRKR | Marker Therapeutics, Inc. | 15.11M | -5.59% | 217,610 | 3.55M |
| 476 | ATYR | aTyr Pharma, Inc. | 15.05M | -7.09% | 3,291,803 | 190.00K |
| 477 | NCEL | NewcelX Ltd. | 14.73M | -4.14% | 16,194 | - |
| 478 | ALLR | Allarity Therapeutics, Inc. | 14.56M | 5.74% | 174,220 | 345.00K |
| 479 | GUTS | Fractyl Health, Inc. | 14.19M | -0.93% | 363,050 | 3.00K |
| 480 | KPRX | Kiora Pharmaceuticals, Inc. | 14.06M | -3.49% | 24,984 | 20.00K |
| 481 | PBM | Psyence Biomedical Ltd. | 13.96M | -12.12% | 46,132 | - |
| 482 | PLUR | Pluri Inc. | 13.83M | 13.13% | 490,458 | 1.02M |
| 483 | BCDA | BioCardia, Inc. | 13.65M | -2.12% | 129,624 | 3.00K |
| 484 | KTTA | Pasithea Therapeutics Corp. | 13.36M | -1.23% | 628,873 | - |
| 485 | ICU | SeaStar Medical Holding Corporation | 12.99M | 2.49% | 102,691 | 1.71M |
| 486 | TCRX | TScan Therapeutics, Inc. | 12.86M | -6.64% | 801,334 | 7.11M |
| 487 | BOLT | Bolt Biotherapeutics, Inc. | 12.69M | 5.10% | 423,696 | 4.70M |
| 488 | ACTU | Actuate Therapeutics, Inc. | 12.68M | 11.09% | 236,324 | - |
| 489 | DARE | Daré Bioscience, Inc. | 12.66M | -0.33% | 50,548 | 1.37M |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 12.33M | 11.38% | 377,887 | 7.11M |
| 491 | HIND | Vyome Holdings, Inc. | 12.00M | -4.47% | 16,716 | 129.73K |
| 492 | AEON | AEON Biopharma, Inc. | 11.97M | 0.04% | 110,495 | - |
| 493 | LPCN | Lipocine Inc. | 11.95M | 0.69% | 108,938 | 1.57M |
| 494 | CNSY | Cerenome, Inc. | 11.92M | -4.27% | 74,046 | 4.20M |
| 495 | CLRB | Cellectar Biosciences, Inc. | 11.44M | -0.82% | 184,737 | - |
| 496 | TVRD | Tvardi Therapeutics, Inc. | 11.23M | -10.41% | 139,585 | - |
| 497 | GDTC | CytoMed Therapeutics Limited | 11.05M | 0.78% | 12,490 | 609.73K |
| 498 | KPTI | Karyopharm Therapeutics Inc. | 10.93M | -6.84% | 1,365,207 | 146.62M |
| 499 | PASG | Passage Bio, Inc. | 10.81M | -0.33% | 1,635 | - |
| 500 | PPBT | Purple Biotech Ltd | 10.49M | -6.48% | 8,335 | - |